Randomized trial · people
Pramlintide-insulin loop: time in range held without carb counting
Checked against the paper Randomized trialPublished by PepVault
The takeaway
Early evidence suggests that adding pramlintide to an automated insulin system may let people with type 1 diabetes skip carb counting without losing time in range, but the trial was too small and short to settle it.
- Kind
- Randomized trial
- Studied in
- People
- Number studied
- 12
- Published
- 2025
- Journal
- J Diabetes Sci Technol
What they tested
Could an automated system that delivers both insulin and pramlintide control blood sugar in type 1 diabetes without people counting the carbohydrates in their meals?
How the study was done
A small pilot randomized, controlled trial in 12 adults with type 1 diabetes. Each person went through 5 arms of 14 hours each, outpatient and supervised in daily life: faster aspart insulin with carb counting (the control), or a fully closed-loop system (one that doses automatically) giving faster aspart or aspart with pramlintide at 8 µg/U or 10 µg/U ratios, with no carb counting.

What they found
Median time in the target range of 3.9-10.0 mmol/L was 78.6 in the carb-counting control arm. With the closed-loop faster aspart and pramlintide system it was 76.2 at the 8 µg/U ratio and 78.8 at the 10 µg/U ratio; with aspart and pramlintide it was 65.9 at 8 µg/U and 77.4 at 10 µg/U. Time spent below 3.9 and 3.0 mmol/L, meaning low blood sugar, was numerically higher in the aspart and pramlintide arms than in the control arm. None of these differences were statistically significant.
What it doesn’t show
This was a pilot trial in only 12 adults, with each setup tested for just 14 hours, so it cannot show how the system performs over weeks or months. The authors say a longer and larger study is underway.
The paper
Odabassian et al. A Pilot Outpatient Assessment of a Fully Closed-Loop Insulin and Pramlintide System. J Diabetes Sci Technol. 2025.
The compound
More studies on Pramlintide
- Pramlintide: HbA1c down 0.43% vs placebo at 26 weeks with insulinMeta-analysis · people · 2003
- Pramlintide-insulin mix: 2.1 kg more weight loss than lisproRandomized trial · people · 2024
- Pramlintide/insulin ADO09 cut meal glucose rise 69% in high-dose groupRandomized trial · people · 2023
- Pramlintide: weight loss maintained over 12 months in obesityRandomized trial · people · 2008
- Pramlintide: 3.7% placebo-corrected weight loss at 16 weeksRandomized trial · people · 2007
- Pramlintide lowered post-meal glucagon and glucose in type 2 diabetesRandomized trial · people · 2002
- Every study on Pramlintide
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.